Atlas Trials

A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases

Clinical trial NCT03127319 · UNKNOWN

Trial details

NCT number
NCT03127319
Sponsor
Affiliated Hospital of Hebei University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-squamous Non-small Cell Lung Cancer
Start date
2017-07-03
Primary completion
2019-04-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.